The long term goal of this project is the generation of pancreatic beta-cell lines for cell therapy of diabetes. The approach taken by our laboratory involves induction of beta-cell proliferation by expression of a transforming oncogene, the SV40 large T antigen (Tag), coupled with genetic switches to limit oncogene expression. This approach is based on our findings that transformed beta cells are dependent on continuous expression of the Tag oncogene for their proliferation. It allows expansion of the beta-cell mass in culture, followed by growth arrest and enhanced differentiation upon transplantation in vivo. We will utilize two genetic systems for reversible transformation of pancreatic beta cells in transgenic mice. The first will involve Tag expression in beta cells under control of the reverse tetracycline regulatory system. Oncogene expression can be induced in this system by administration of tetracycline or its derivatives in vivo or in tissue culture. The second approach will utilize the bacterial cre-loxP DNA recombination system to conditionally delete the Tag oncogene, as an approach to reverse transformation in beta-cell lines derived from transgenic mice. Both approaches will allow studies on the effects of cell proliferation and growth arrest on differentiated beta-cell functions, such as insulin biosynthesis and regulated secretion in response to a variety of secretagogues, expression of glucose phosphorylating enzymes and glucose transporter isotypes, and the ability to reverse diabetes in syngeneic mouse recipients.

Project Start
1999-01-15
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Lu, Zhonglei; Marcelin, Genevieve; Bauzon, Frederick et al. (2013) pRb is an obesity suppressor in hypothalamus and high-fat diet inhibits pRb in this location. EMBO J 32:844-57
Kakabadze, Zurab; Gupta, Sanjeev; Brandhorst, Daniel et al. (2011) Long-term engraftment and function of transplanted pancreatic islets in vascularized segments of small intestine. Transpl Int 24:175-83
Cheng, Kang; Follenzi, Antonia; Surana, Manju et al. (2010) Switching of mesodermal and endodermal properties in hTERT-modified and expanded fetal human pancreatic progenitor cells. Stem Cell Res Ther 1:6
Brims, Daniel R; Qian, Jie; Jarchum, Irene et al. (2010) Predominant occupation of the class I MHC molecule H-2Kwm7 with a single self-peptide suggests a mechanism for its diabetes-protective effect. Int Immunol 22:191-203
Jarchum, Irene; DiLorenzo, Teresa P (2010) Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin. J Immunol 184:658-65
Kojaoghlanian, T; Joseph, A; Follenzi, A et al. (2009) Lentivectors encoding immunosuppressive proteins genetically engineer pancreatic beta-cells to correct diabetes in allogeneic mice. Gene Ther 16:340-8
Jarchum, Irene; Takaki, Toshiyuki; DiLorenzo, Teresa P (2008) Efficient culture of CD8(+) T cells from the islets of NOD mice and their use for the study of autoreactive specificities. J Immunol Methods 339:66-73
Antal, Zoltan; Jarchum, Irene; DiLorenzo, Teresa P (2008) HLA class I supertypes in type 1 diabetic children in an urban children's hospital. Ann N Y Acad Sci 1150:86-9
Chaparro, Rodolfo Jose; Burton, Amanda R; Serreze, David V et al. (2008) Rapid identification of MHC class I-restricted antigens relevant to autoimmune diabetes using retrogenic T cells. J Immunol Methods 335:106-15
Inada, Mari; Follenzi, Antonia; Cheng, Kang et al. (2008) Phenotype reversion in fetal human liver epithelial cells identifies the role of an intermediate meso-endodermal stage before hepatic maturation. J Cell Sci 121:1002-13

Showing the most recent 10 out of 40 publications